TD Asset Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.9M | Sell |
159,256
-36,044
| -18% | -$3.92M | 0.02% | 474 |
|
|
2026
Q1 | $18M | Buy |
195,300
+14,252
| +8% | +$1.43M | 0.01% | 533 |
|
|
2025
Q4 | $18.5M | Sell |
181,048
-7,762
| -4% | -$694K | 0.01% | 529 |
|
|
2025
Q3 | $11.8M | Buy |
188,810
+26,210
| +16% | +$1.43M | 0.01% | 613 |
|
|
2025
Q2 | $8.46M | Buy |
162,600
+118,886
| +272% | +$5.31M | 0.01% | 676 |
|
|
2025
Q1 | $1.86M | Buy |
+43,714
| New | +$1.89M | ﹤0.01% | 983 |
|
|
2024
Q3 | – | Sell |
-34,040
| Closed | -$983K | – | 1405 |
|
|
2024
Q2 | $983K | Sell |
34,040
-78,884
| -70% | -$1.84M | ﹤0.01% | 1163 |
|
|
2024
Q1 | $2.33M | Sell |
112,924
-25,720
| -19% | -$551K | ﹤0.01% | 969 |
|
|
2023
Q4 | $3.75M | Sell |
138,644
-146,200
| -51% | -$3.84M | ﹤0.01% | 822 |
|
|
2023
Q3 | $8.44M | Buy |
284,844
+109,662
| +63% | +$3.86M | 0.01% | 616 |
|
|
2023
Q2 | $6.27M | Buy |
175,182
+79,117
| +82% | +$2.27M | 0.01% | 692 |
|
|
2023
Q1 | $2.25M | Hold |
96,065
| – | – | ﹤0.01% | 949 |
|
|
2022
Q4 | $2.61M | Buy |
96,065
+8,847
| +10% | +$405K | ﹤0.01% | 914 |
|
|
2022
Q3 | $4.68M | Buy |
87,218
+16,000
| +22% | +$821K | 0.01% | 773 |
|
|
2022
Q2 | $2.87M | Buy |
71,218
+4,776
| +7% | +$237K | ﹤0.01% | 898 |
|
|
2022
Q1 | $4.4M | Buy |
66,442
+1,105
| +2% | +$75.6K | ﹤0.01% | 850 |
|
|
2021
Q4 | $6.54M | Sell |
65,337
-9,600
| -13% | -$993K | 0.01% | 796 |
|
|
2021
Q3 | $9.37M | Buy |
74,937
+11,676
| +18% | +$1.39M | 0.01% | 667 |
|
|
2021
Q2 | $6.95M | Buy |
63,261
+8,700
| +16% | +$1.17M | 0.01% | 747 |
|
|
2021
Q1 | $8.33M | Buy |
54,561
+13,613
| +33% | +$2.06M | 0.01% | 688 |
|
|
2020
Q4 | $5.28M | Buy |
40,948
+15,400
| +60% | +$1.77M | 0.01% | 776 |
|
|
2020
Q3 | $2.86M | Buy |
25,548
+1,800
| +8% | +$165K | ﹤0.01% | 833 |
|
|
2020
Q2 | $1.93M | Hold |
23,748
| – | – | ﹤0.01% | 884 |
|
|
2020
Q1 | $1.65M | Sell |
23,748
-8,400
| -26% | -$645K | ﹤0.01% | 873 |
|
|
2019
Q4 | $2.51M | Hold |
32,148
| – | – | ﹤0.01% | 880 |
|
|
2019
Q3 | $2.05M | Sell |
32,148
-3,922
| -11% | -$346K | ﹤0.01% | 907 |
|
|
2019
Q2 | $3.11M | Buy |
36,070
+15,715
| +77% | +$1.2M | ﹤0.01% | 814 |
|
|
2019
Q1 | $1.56M | Hold |
20,355
| – | – | ﹤0.01% | 954 |
|
|
2018
Q4 | $765K | Buy |
+20,355
| New | +$750K | ﹤0.01% | 1122 |
|
Other funds holding GH
DTC
TD Asset Management's GH Position: Q2 2026 in Review
TD Asset Management reduced its Guardant Health (GH) stake by 18% in Q2 2026, selling an estimated $3.92M and leaving 159,256 shares worth $23.9M. The position accounts for 0.02% of the portfolio, ranked #474.
TD Asset Management first reported a position in GH in Q4 2018 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- TD Asset Management held 159,256 shares of Guardant Health worth $23.9M as of Q2 2026.
- TD Asset Management sold 36,044 Guardant Health shares in Q2 2026, an estimated $3.92M.
- Guardant Health made up 0.02% of TD Asset Management's portfolio in Q2 2026, its #474 holding.
- TD Asset Management first reported a position in Guardant Health in Q4 2018 and has held it in 29 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.